Doron Merims
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments 11
- Neurological disorders and treatments 10
- Botulinum Toxin and Related Neurological Disorders 2
-
- Genetic Neurodegenerative Diseases 3
- Psychiatry and Mental health top 10%
- Dementia and Cognitive Impairment Research 7
- Schizophrenia research and treatment 2
-
- Balance, Gait, and Falls Prevention 3
-
- Stroke Rehabilitation and Recovery 1
Doron Merims
23 papers receiving 715 citations
Peers
Comparison fields: 5 of 83
- Neurology 486
- Cellular and Molecular Neuroscience 164
- Psychiatry and Mental health 111
- Developmental Neuroscience 26
- Neuropsychology and Physiological Psychology 8
Countries citing papers authored by Doron Merims
This map shows the geographic impact of Doron Merims's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doron Merims with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doron Merims more than expected).
Fields of papers citing papers by Doron Merims
This network shows the impact of papers produced by Doron Merims. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doron Merims. The network helps show where Doron Merims may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Doron Merims, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 5 | |
| 2 | 2018 | 3 | |
| 3 | 2014 | 6 | |
| 4 | 2010 | 20 | |
| 5 | 2009 | 30 | |
| 6 | 2008 | 10 | |
| 7 | 2007 | 114 | |
| 8 | 2007 | 5 | |
| 9 | 2006 | 117 | |
| 10 | 2005 | 9 | |
| 11 | 2004 | 69 | |
| 12 | 2003 | 49 | |
| 13 | 2003 | 3 | |
| 14 | 2003 | 35 | |
| 15 | The role of glutamatergic transmission in the pathogenesis of levodopa-induced dyskinesias. Potential therapeutic approaches. | 2001 | 2 |
| 16 | 2000 | 24 | |
| 17 | 2000 | 2 | |
| 18 | 2000 | 21 | |
| 19 | 1999 | 157 | |
| 20 | 1996 | 60 |
About Doron Merims
Doron Merims is a scholar working on Neurology, Physical Therapy, Sports Therapy and Rehabilitation and Neuropsychology and Physiological Psychology, having authored 24 papers that have together received 745 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (11 papers), Neurological disorders and treatments (10 papers), Dementia and Cognitive Impairment Research (7 papers), Balance, Gait, and Falls Prevention (3 papers), Genetic Neurodegenerative Diseases (3 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), Schizophrenia research and treatment (2 papers) and Stroke Rehabilitation and Recovery (1 paper). The work is most often cited by research in Neurology (486 citations), Cellular and Molecular Neuroscience (164 citations) and Psychiatry and Mental health (111 citations). Doron Merims has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Nir Giladi, Eldad Melamed, Ruth Djaldetti, Chava Peretz, Meirav Balas, Herzel Shabtai, H. Shabtai, Israela Lerer, Noam Weizman and N Gadoth. Their work appears in journals such as Movement Disorders, Journal of Neurology and Headache The Journal of Head and Face Pain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.